Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. - Wikidata - wikimedia - TriplyDB

Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

http://www.wikidata.org/entity/Q35789027

about

Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2 Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?Beta-catenin: a transforming actor on many stages Proteotypic classification of spontaneous and transgenic mammary neoplasms Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cells The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells EMT tumorigenesis in the mouse mammary gland.The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis Genetic mechanisms in Apc-mediated mammary tumorigenesis Pea3 transcription factors and wnt1-induced mouse mammary neoplasia Wnt5a Signaling in Normal and Cancer Stem Cells Epithelial to mesenchymal transition and breast cancer.The regulation of β-catenin activity and function in cancer: therapeutic opportunities Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutant.A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice.Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.The pathology of EMT in mouse mammary tumorigenesis.Convergence between Wnt-β-catenin and EGFR signaling in cancer.Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies.Tumor-initiating function of nucleostemin-enriched mammary tumor cells.Control of mammary tumor differentiation by SKI-606 (bosutinib).Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts.Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.Wnt5a as an effector of TGFβ in mammary development and cancer Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene.Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.Isolation and characterization of functional mammary gland stem cells.Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands.Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent.Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.

P2860

Q24672372-624DB870-9A9A-4BB3-85FA-A9657CEEE494 Q24794064-B8C401FA-AE14-41C2-8A04-B80C47A89587 Q24795343-7EA7D60F-DAE2-4514-8769-BB73D1D5E33E Q24795869-E055F38C-72F3-4033-A70B-F6A5FAFC0403 Q24801345-C9052B3F-A626-4461-8C37-8CBAF609097E Q24812718-E1628017-78F1-430B-9068-5981F5BC4E44 Q25257848-76C19A01-E14A-403C-8462-B3B2DE102347 Q27437626-5B5C2931-6B75-4FA2-BA18-377037F5FFB8 Q28749398-200544B5-63E8-4A91-8211-95C00D4C1D71 Q33199519-D7F3CDA1-7FA9-4F0B-8B58-F605B149B249 Q33301901-A526A0CB-7663-4D52-B7DF-CA251E9D1811 Q33371124-670F6CDC-A0F7-4055-ACB5-421A67760AD2 Q33406237-7EF65112-C44F-497E-A209-F1F37F5CD7FE Q33526975-A8CBFA90-3865-48AC-9396-DE12F9C477FA Q33604792-859F1831-EDC0-449D-8D4E-EB8F43CC7AC3 Q33627118-DD24EBA8-41FC-4EE6-BE60-C644D680E515 Q33779745-369E88AB-91B5-48C8-9A86-7A41B4AF074A Q33831941-AB3D56FF-B755-448A-9A57-BEB2907AF3D8 Q33835581-481C5116-9437-4004-9C4C-9106BA5573AF Q33837788-579DABD0-064A-4B1C-AC29-647D2FA05A6A Q33882525-113E23F1-47B9-4500-B2BC-55BBBEDC4E35 Q33915129-9A5A7286-D4D8-47E7-8364-BE16B92CDF32 Q34149071-A5734FE0-940B-48BA-8B27-E9830D3C728C Q34205443-4CCCD21F-DD26-4E36-8777-E3F04CFDB60B Q34316303-9406FD42-BCE7-4813-BCFF-501AA5F3AE88 Q34398204-3098B9B5-A883-45F0-AD78-2940832AF591 Q34580042-5C0CA0B0-6EBC-4EB9-A0D4-A7B13E7BFADF Q34650297-5CA4D353-81A2-485F-94FF-42225BDBBA13 Q34792452-6AEDDEAA-B34A-4AFE-ADFA-2837C847EB93 Q35022625-4506307D-9011-4D65-9360-12CF4E812DC2 Q35070697-41CEDF13-1DD7-4248-8960-AB70BE721332 Q35085039-59A0DFA5-55B0-49F5-BEFE-9AC957C0C4C6 Q35121912-7C3AF9C1-F0C0-4494-B8FE-7382179D4D23 Q35166902-B2001E39-6A27-4D19-AE83-77A8BAA92E6B Q35169909-FE9CFB52-6220-42D3-96CA-CDC9460D4D9F Q35234634-21FD46C2-2FFD-4FF3-AAFF-C9C618258E19 Q35548230-C0FA3928-7FBB-4A84-BFB7-0275E9B71980 Q35641656-D11E3ADC-15A1-4CBF-BA4E-76EBAF420E7F Q35663861-A3236637-1D8C-4F55-B947-452281639C56 Q35683502-F5AC82AD-CC16-47A6-A4B4-E4D61ECFFBD5

P2860

Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

http://www.wikidata.org/entity/Q35789027

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Pathway pathology: histologica ...... way transgenic mammary tumors.

@ast

Pathway pathology: histologica ...... way transgenic mammary tumors.

@en

type

label

Pathway pathology: histologica ...... way transgenic mammary tumors.

@ast

Pathway pathology: histologica ...... way transgenic mammary tumors.

@en

prefLabel

Pathway pathology: histologica ...... way transgenic mammary tumors.

@ast

Pathway pathology: histologica ...... way transgenic mammary tumors.

@en

P1433

Q35789027-91FA2A69-2A8C-4BD0-9127-3F31DADCE7A9

P1476

Q35789027-EDDB37E9-D864-4FB4-93FC-8B1BC8E5697A

P2093

Q35789027-0907EB80-61F8-4479-8CFA-580A504333E2

Q35789027-14A397AE-C494-43F7-9E55-2F86DFDC635D

Q35789027-1CC20E61-3F1A-45E5-8D67-351892CEAF64

Q35789027-212B832B-C964-4BC8-A3AA-99BAFC40AB75

Q35789027-30A0EFF7-902A-4C9D-8495-0BE277258E87

Q35789027-492E1FB1-15BF-4AFF-ADAA-E299AC446504

Q35789027-5507C938-8150-42C7-B0E4-C98784A59C5E

Q35789027-77AFB63C-F9AB-4024-838E-1F0904D5ABFC

Q35789027-87E66CF7-8B08-461A-9EBC-56924064EFE8

Q35789027-DE40569F-564B-49FB-9774-5C9D7141B32D

P2860

Q35789027-02E64DEE-9AB5-44B2-A813-9F09BDBAC781

Q35789027-0D363D9E-14B3-4579-9FC7-E98FC35F69B5

Q35789027-0EC299C6-6F79-4EFF-9A86-DB51AD606424

Q35789027-1FC93C61-6EFE-4A0F-B4C9-2278FAAA15ED

Q35789027-251FA4EF-5B1D-4657-97A6-29201A096979

Q35789027-2B9FF9B8-0DAE-485A-8D43-F9E08EB16294

Q35789027-2D138C32-4059-469A-A556-4EB57ACACF4F

Q35789027-2D55A97C-F60B-459C-92CD-D5B8B8C3E4C2

Q35789027-3328C8E1-1A44-40DA-93E4-B17BCC78C0BB

Q35789027-3C63C4F2-42DB-47E0-8AAF-F629A41160BA

P304

Q35789027-5D214122-7B25-4EC9-90C1-801E324BA630

P31

Q35789027-27D66603-49E1-416A-BA01-FCF717090546

P356

Q35789027-D7283565-37C6-4FD1-B1AE-FC7A5ED3E0E0

P407

Q35789027-3B806B7F-4140-431B-83E4-63E7B89A1BFA

P433

Q35789027-C33BBFCA-1BFE-4BFE-8784-32837F6C5DF3

P478

Q35789027-362CF21A-5397-4FA6-B96B-87793D84528D

P577

Q35789027-4F511B4E-A257-4708-988D-D918F330D2F6

P698

Q35789027-45785B54-AC79-4530-8BA4-7A3DA37EA042

P932

Q35789027-04E048B4-1655-4018-B369-D2FB1F5AD7CC

P356

S0002-9440(10)64269-1

P1433

The American Journal of Pathology

P1476

Pathway pathology: histologica ...... way transgenic mammary tumors.

@en

P2093

Amy E Gillgrass

http://www.w3.org/2001/XMLSchema#string

Amy R Moser

http://www.w3.org/2001/XMLSchema#string

Andrea Rosner

http://www.w3.org/2001/XMLSchema#string

Carol L MacLeod

http://www.w3.org/2001/XMLSchema#string

David C Seldin

http://www.w3.org/2001/XMLSchema#string

Esther Landesman-Bollag

http://www.w3.org/2001/XMLSchema#string

G Shyamala

http://www.w3.org/2001/XMLSchema#string

Keiko Miyoshi

http://www.w3.org/2001/XMLSchema#string

Robert D Cardiff

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor specificity of the fibroblast growth factor family

A common human skin tumour is caused by activating mutations in beta-catenin

Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells

beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice

Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability

Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain

Wnt signaling: a common theme in animal development

De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin

P304

1087-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64269-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12213737

http://www.w3.org/2001/XMLSchema#string

P932

1867237

http://www.w3.org/2001/XMLSchema#string